Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Ask Vendit Off-Topic Questions -- Ignore unavailable to you. Want to Upgrade?

To: MJ who wrote (2323)	11/28/2004 9:42:08 PM
From: Vendit™	Read Replies (1) \| Respond to of 8752

MJ, ISIS shows up on a regular basis on my daily scans. Below is a list that looks good "technically" for Monday's open. Remember that "news" will always trump a good technical setup. <g> I did a scan and I compiled a short list of stocks with nice technical setups through Friday’s close: EP / as a possible short: (very explosive) I mentioned EP as a long play prior to Friday’s open. (11.61% gain on that day makes me a lucky guesser) 139.142.147.221 WOR / a possible long. Nice setup with confirmed buy signals in mid-stream. 139.142.147.221 BSX long / about to make a power move up, based on MACD. 139.142.147.221 DCLK / should push to the top of the upper Bollinger Band tomorrow. Nice steady up trend. 139.142.147.221 GTW / MACD suggest a possible explosive move up within 2 or 3 sessions. An extremely bullish chart. 139.142.147.221 These are all viewed be me as short term trades. Be trigger happy. <g> Reid

To: MJ who wrote (2323)	11/29/2004 1:50:24 AM
From: Walkingshadow	Respond to of 8752

Hi MJ, I think a lot of the interest in ALNY has to do with the fact that they are taking the lead into clinical trials with RNAi. The macular degeneration trial should begin any time now, and there are several more that I am aware of that are gearing up to begin early next year. I expect this is only the beginning. Wall Street doesn't even know what RNAi stands for. Yet. Once they discover that, I think this will play out the same way we saw with genomo-momo, nano-nano momo, and stem cell momo. The mo-mo crowd knows they can easily overhype anything that is cutting-edge, exotic, not easily understood by Joe Sixpack (or Joe Analyst), and hints at the possibility of major advances. RNAi has all these key features. But another ingredient is needed: a float they can readily push around. And that requires as few trading shares as possible, and a low stock price. ALNY and RNAi have floats of 11 to 12 million shares, so at current prices, the entire trading float is worth $36 million (RNAi) to $72 million (ALNY). Not ideal, but not bad. For comparison purposes, when they really jumped on TZOO, it was trading at about $25/share, with a microfloat of 2.1 million. Multiply one by the other and you get about $52 million. So, I'd say RNAi and ALNY both fall roughly within range in that regard. There's one more thing to consider here, and that is the shorts. The mo-mo crowd favors highly shorted stocks because it amplifies upside through short-squeezes, and blunts downside because of short profit-taking. Not surprisingly then, the mo-mo favorite TZOO is one of the most heavily shorted stocks; 69% of the float is shorted. But ALNY and RNAI have vanishingly small short interest (2% of the float or less). So that is not a plus. But all in all, I think the mo-mo crowd will eventually bite, I just don't know exactly when that might be. My guess is sometime in the next 3 months or so, but it could be much sooner if there is some kind of catalyst. When you start seeing a huge ramp-up in volume of stocks like ALNY and RNAI, then you know the mo-mo feeding frenzy has begun. We have seen some nibbles in volume so far, at least with ALNY. The 3 month average of the daily volume is 45,000, but the 10 day average of daily volume is triple that at 135,000. For RNAI, there is just a slight increase at best. I suspect these volumes will exceed 1 million in the not-too-distant future, and could go well beyond that. JMVHO...... T